Acalculous cholecystitis associated with levodopa-carbidopa intestinal infusion therapy: A case report.
Journal
Clinical parkinsonism & related disorders
ISSN: 2590-1125
Titre abrégé: Clin Park Relat Disord
Pays: England
ID NLM: 101761473
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
04
2022
revised:
18
06
2022
accepted:
24
06
2022
entrez:
20
7
2022
pubmed:
21
7
2022
medline:
21
7
2022
Statut:
epublish
Résumé
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is one of the primary therapies for improving advanced Parkinson's disease symptoms. Placement of the jejunal catheter through the abdominal wall for drug administration requires a percutaneous interventional procedure called percutaneous endoscopic gastrostomy (PEG). PEG is considered a safe and straightforward procedure, and it is performed very commonly in clinical practice. In the context of LCIG treatment, severe adverse events have been identified, such as intestinal bleeding and acute abdomen [1], but acute acalculous cholecystitis (AAC) has never been reported.
Identifiants
pubmed: 35856047
doi: 10.1016/j.prdoa.2022.100150
pii: S2590-1125(22)00021-4
pmc: PMC9287348
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100150Informations de copyright
© 2022 The Authors. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Clin Gastroenterol Hepatol. 2010 Jan;8(1):15-22
pubmed: 19747982
Mov Disord. 2012 Nov;27(13):1704-5
pubmed: 23192929
Parkinsonism Relat Disord. 2018 Sep;54:107-109
pubmed: 29661695
Parkinsonism Relat Disord. 2021 Jun;87:56-60
pubmed: 33964787